The global antidepressants market size is projected to reach USD 18.29 billion by 2027, exhibiting a CAGR of 2.9% during the forecast period. The skyrocketing demand for depression management drugs amid the COVID-19 pandemic will rapidly broaden the horizons of this market, observes Fortune Business Insights™
Click here to get the short-term and long-term impacts of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/antidepressants-market-105017
List of Key Companies Covered in this Market Report:
Teva Pharmaceutical Industries Ltd. (Petah Tikva, Israel)
AstraZeneca (Cambridge, U.K)
Pfizer Inc. (New York, U.S)
Eli Lilly and Company (Indiana, U.S)
H. Lundbeck A/S (Denmark, Europe)
Bristol-Myers Squibb (New York, U.S)
Merck Co. Inc. (New Jersey, U.S)
Janssen Pharmaceuticals (Beerse, Belgium)
GlaxoSmithKline plc (Brentford, U.K)
Some major points from Table of Content:
Introduction
Market Scope
Market Segmentation
Market Methodology
Definitions and Assumptions
Executive Summary
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Key Insights
Prevalence of Anxiety Depression –Key Regions/Country
New Product Launch
Pipeline Analysis
Impact of COVID-19 on the Market
Key Industry Developments - Mergers, Acquisitions, and Partnerships
Global Antidepressants Market Analysis, Insights and Forecast, 2016-2027
Key Findings / Summary
Market Analysis, Insights and Forecast – By Drug Class
Selective Serotonin Reuptake Inhibitors (SSRIs)
Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
Atypical Antidepressants
Tricyclic Antidepressants (TCAs)
Monoamine Oxidase Inhibitors (MAOIs)
Others
Market Analysis, Insights and Forecast – By Disorder
Major Depressive Disorder
Obsessive Compulsive Disorder
Generalized Anxiety Disorder
Panic Disorder
Others
Market Analysis, Insights and Forecast – By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Market Analysis, Insights and Forecast – By Geography
North America
Europe
Asia Pacific
Latin America
Middle East Africa
